Skip to main content
AAN.com
Brief Communications
September 10, 2002

Corticosteroid- responsive asymmetric neuropathy with a myelin protein zero gene mutation

September 10, 2002 issue
59 (5) 767-769

Abstract

A patient with hereditary neuropathy presented with asymmetric distal weakness. On nerve biopsy, there was demyelination and onion-bulb formation, and molecular analysis revealed that the patient was heterozygous for an MPZ mutation. The patient improved with corticosteroid treatment.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Dyck PJ, Swanson CJ, Low PA, et al. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc . 1982; 57: 239–246.
2.
Bird SJ, Sladky JT. Corticosteroid-responsive dominantly inherited neuropathy in childhood. Neurology . 1991; 41: 437–439.
3.
Donaghy M, Sisodiya SM, Kennett R, et al. Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation. J Neurol Neurosurg Psychiatry . 2000; 69: 799–805.
4.
Hayasaka K, Ohnishi A, Takada G, Fukushima Y, Murai Y. Mutation of the myelin Po gene in Charcot–Marie–Tooth neuropathy type 1. Biochem Biophys Res Commn . 1993; 194: 1317–1322.
5.
Ohnishi A, Ohnari K, Hashimoto T, Hayasaka K, Yoshimura T, Fukushima Y. A family of hereditary motor and sensory neuropathy type I with a new type of myelin Po mutation. Clin Neurol . 1994; 34: 546–551.
6.
Rouger H, LeGuern E, Gouider R, et al. High frequency of mutations in codon 98 of the peripheral myelin protein Po gene in 20 French CMT1 patients. Am J Hum Genet . 1996; 58: 638–641.

Information & Authors

Information

Published In

Neurology®
Volume 59Number 5September 10, 2002
Pages: 767-769
PubMed: 12221176

Publication History

Received: September 12, 2001
Accepted: May 10, 2002
Published online: September 10, 2002
Published in print: September 10, 2002

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

M. Watanabe, MD, PhD
From the Department of Neurology (Drs. Watanabe, Ohkoshi, Kohno, Hayashi, Tamaoka, and Shoji), Institute of Clinical Medicine, University of Tsukuba; and Division of Clinical Neurology and Neuroscience (Dr. Nagata and N. Yamamoto), Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, Japan.
N. Yamamoto, MS
From the Department of Neurology (Drs. Watanabe, Ohkoshi, Kohno, Hayashi, Tamaoka, and Shoji), Institute of Clinical Medicine, University of Tsukuba; and Division of Clinical Neurology and Neuroscience (Dr. Nagata and N. Yamamoto), Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, Japan.
N. Ohkoshi, MD, PhD
From the Department of Neurology (Drs. Watanabe, Ohkoshi, Kohno, Hayashi, Tamaoka, and Shoji), Institute of Clinical Medicine, University of Tsukuba; and Division of Clinical Neurology and Neuroscience (Dr. Nagata and N. Yamamoto), Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, Japan.
H. Nagata, MD, PhD
From the Department of Neurology (Drs. Watanabe, Ohkoshi, Kohno, Hayashi, Tamaoka, and Shoji), Institute of Clinical Medicine, University of Tsukuba; and Division of Clinical Neurology and Neuroscience (Dr. Nagata and N. Yamamoto), Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, Japan.
Y. Kohno, MD
From the Department of Neurology (Drs. Watanabe, Ohkoshi, Kohno, Hayashi, Tamaoka, and Shoji), Institute of Clinical Medicine, University of Tsukuba; and Division of Clinical Neurology and Neuroscience (Dr. Nagata and N. Yamamoto), Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, Japan.
A. Hayashi, MD, PhD
From the Department of Neurology (Drs. Watanabe, Ohkoshi, Kohno, Hayashi, Tamaoka, and Shoji), Institute of Clinical Medicine, University of Tsukuba; and Division of Clinical Neurology and Neuroscience (Dr. Nagata and N. Yamamoto), Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, Japan.
A. Tamaoka, MD, PhD
From the Department of Neurology (Drs. Watanabe, Ohkoshi, Kohno, Hayashi, Tamaoka, and Shoji), Institute of Clinical Medicine, University of Tsukuba; and Division of Clinical Neurology and Neuroscience (Dr. Nagata and N. Yamamoto), Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, Japan.
S. Shoji, MD, PhD
From the Department of Neurology (Drs. Watanabe, Ohkoshi, Kohno, Hayashi, Tamaoka, and Shoji), Institute of Clinical Medicine, University of Tsukuba; and Division of Clinical Neurology and Neuroscience (Dr. Nagata and N. Yamamoto), Center for Medical Sciences, Ibaraki Prefectural University of Health Sciences, Japan.

Notes

Address correspondence and reprint requests to Dr. M. Watanabe, Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305, Japan; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Charcot–Marie–Tooth Disease with Myelin Protein Zero Mutation Presenting as Painful, Predominant Small-Fiber Neuropathy, International Journal of Molecular Sciences, 25, 3, (1654), (2024).https://doi.org/10.3390/ijms25031654
    Crossref
  2. Case report: Chronic inflammatory demyelinating polyneuropathy superimposed on Charcot–Marie-tooth type 1A disease after SARS-CoV-2 vaccination and COVID-19 infection, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1358881
    Crossref
  3. Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology, Journal of the Peripheral Nervous System, 29, 2, (135-160), (2024).https://doi.org/10.1111/jns.12625
    Crossref
  4. Clinical Worsening of Charcot-Marie-Tooth Disease Due to Overlapping Acute Inflammatory Polyneuropathy, Cureus, (2023).https://doi.org/10.7759/cureus.47750
    Crossref
  5. Genetic neuropathies presenting with CIDP-like features in childhood, Neuromuscular Disorders, 31, 2, (113-122), (2021).https://doi.org/10.1016/j.nmd.2020.11.013
    Crossref
  6. Remyelination in PNS and CNS: current and upcoming cellular and molecular strategies to treat disabling neuropathies, Molecular Biology Reports, 48, 12, (8097-8110), (2021).https://doi.org/10.1007/s11033-021-06755-6
    Crossref
  7. Charcot–Marie–Tooth disease and neuroinflammation, Clinical and Experimental Neuroimmunology, 11, 2, (109-116), (2020).https://doi.org/10.1111/cen3.12566
    Crossref
  8. Immune-mediated inflammatory polyneuropathy overlapping Charcot-Marie-Tooth 1B, Journal of Clinical Neuroscience, 75, (228-231), (2020).https://doi.org/10.1016/j.jocn.2020.03.014
    Crossref
  9. Recessive Charcot-Marie-Tooth and multiple sclerosis associated with a variant in MCM3AP, Brain Communications, 1, 1, (2019).https://doi.org/10.1093/braincomms/fcz011
    Crossref
  10. Infantile-Onset Myelin Protein Zero–Related Demyelinating Neuropathy Presenting as an Upper Extremity Monoplegia, Seminars in Pediatric Neurology, 26, (52-55), (2018).https://doi.org/10.1016/j.spen.2017.03.005
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share